Page 2 - Cadila Healthcare

India to target children for Covid-19 vaccine from October: Report

Zydus Cadila's Covid vaccine ZyCoV-D will be given

Stocks to watch: SBI Card, Adani Ports, Cadila Healthcare, HCL Tech, AU SFB

IT company AGC Networks on Monday said its board has approved the appointment of Essar Group's Anshuman Ruia as executive director of the company

Zydus to sell two brands to PE firm True North's portfolio company

Both drugs, Mifegest Cytolog are used for medical termination of pregnancy

Cadila jumps nearly 8% after Covid-19 vaccine gets India emergency use nod

Shares of Cadila Healthcare Ltd jumped 7.9% on Monday after India last week approved the drugmaker's Covid-19 vaccine for emergency use in adults and children aged 12 years and above

Back to old normal: Pharma industry returns to pre-pandemic growth level

In this first instalment of a four-part series on how some of the defining numbers in key sectors are springing back to the pre-pandemic level, Sohini Das looks at India's pharmaceutical sector

Cadila arm completes sale of animal health business for Rs 2,921 crore

Cadila Healthcare on Thursday said its wholly-owned subsidiary Zydus Animal Health and Investment has completed sale of its animal healthcare established markets

Two stock ideas by Vaishali Parekh: Buy CESC, Cadila Healthcare

Cadila Healthcare's stock has taken base near Rs 600 levels on two occasions recently, forming a good support zone

Cadila Healthcare arm recalls 21,240 bottles of diabetes drug in US

Viona Pharmaceuticals Inc is recalling over 21,000 bottles of metformin hydrochloride extended-release tablets manufactured by Ahemdabad-based Cadila Healthcare

Cadila, Bayer to extend JV partnership for three years: Statement

Cadila Healthcare and Bayer (South East Asia) have decided to extend the operations of their joint venture by three years with effect from June

Zydus Cadila seeks regulator nod for clinical trials on Covid-19 therapy

Company says product helps treating mild coronavirus patients and reduces hospitalisation.

Zydus Cadila to sell India animal health business for Rs 2,921 crore

We are sure that ZAHL will continue to grow and strengthen its position, said Pankaj Patel

Multiples Alternate Asset Mgt-led group to buy Cadila's animal health biz

The deal is to sell one of Cadila's two businesses on a slump sale basis as a going concern, for a lump sum of Rs 2,921 cr on cash-free and debt-free basis

Cadila Healthcare's Hepatitis C drug gets approval for emergency use

Approval from the drug regulator follows late-stage study of the medicine

Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May

The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs

Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Nifty outlook and stock picks by Sameet Chavan: Buy BPCL, sell Axis Bank

Price-wise, BPCL's stock seems to have a sturdy structure on the weekly time frame and, looking at the lower degree chart, the recent price correction appears to have completed

Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec

The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks

Stocks to watch: RCFL, Tata Motors, RIL, BEML, Cadila Health, Adani Green

Tata Motors reported a 21 per cent increase in total vehicle sales in the domestic market to 53,430 units in December

Cadila Healthcare completes phase-2 trial of Hepatitis C drug for Covid-19

95% subjects in the test who received a single dose of PegiHepTM along with SOC became virus free as assessed by RT-PCR on day 14, compared to 68% of those who only received SOC

Indices rally for 5th straight day, Sensex up 553 pts; RIL, financials gain

All that happened in the markets today